G. De Cataldis

Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101)

P. Comella, Gianfranco Filippelli, G. De Cataldis et al. · Annals of Oncology · 2006 · 47 citations · Full text

Oncology, Medicine, Phase Iii +7

Carboplatin–oral etoposide personalised dosing in elderly non-small cell lung cancer patients

G. Frasci, P. Comella, N. Panza et al. · European Journal of Cancer · 1998 · 26 citations

Medicine, Cancer Management, Carboplatin–oral Etoposide +5

Addition of either irinotecan or methotrexate to bolus5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: a randomised study by the Southern Italy Cooperative Oncology Group

P. Comella, E. Crucitta, Ferdinando De Vita et al. · Annals of Oncology · 2002 · 24 citations

Gastrointestinal Oncology, Medicine, High-dose Folinic Acid +8

Cisplatin-gemcitabine, vs. cisplatin-gemcitabine-vinorelbine, vs. cisplatin-gemcitabine-paclitaxel in advanced non-small-cell lung cancer. First-stage analysis of a Southern Italy Cooperative Oncology Group (SICOG) phase III trial

P. Comella, G. Frasci, N. Panza et al. · Lung Cancer · 2000 · 16 citations

Medicine, Metronomic Therapy, Phase Iii Trial +9

Gemcitabine + vinorelbine (GV) yields better survival than vinorelbine (V) alone in elderly non-small cell lung cancer (NSCLC) patients. Final analysis of a Southern Italy Cooperative Oncology Group (SICOG) phase III trial

G. Frasci, Vito Lorusso, N. Panza et al. · Lung Cancer · 2000 · 11 citations

Oncology, Cancer Management, Metronomic Therapy +9